For a long time, since its identification in the early 1980s, white coat hypertension (WCH), alternatively termed "isolated clinic hypertension," has widely been considered a completely innocent blood pressure (BP) phenotype, that is, a condition for which the normality of BP outside the medical environment, assessed by ambulatory or home BP monitoring, entails a prognostic value similar to normotension. 1,2 However, challenging this traditional view, an increasing amount of evidence supports the concept that WCH has an intermediate risk between normotension and sustained hypertension. In a recent meta-analysis of 23 cohorts including 20 445 initially untreated individuals, WCH (defined as high clinic BP but normal out-of-office BP, either by ambulatory of home measurements) was associated with an adjusted 38 and 20% increased risk of cardiovascular disease and total mortality compared with normotension. 3
For a long time, since its identification in the early 1980s, white coat hypertension (WCH), alternatively termed "isolated clinic hypertension," has widely been considered a completely innocent blood pressure (BP) phenotype, that is, a condition for which the normality of BP outside the medical environment, assessed by ambulatory or home BP monitoring, entails a prognostic value similar to normotension. 1, 2 However, challenging this traditional view, an increasing amount of evidence supports the concept that WCH has an intermediate risk between normotension and sustained hypertension. In a recent meta-analysis of 23 cohorts including 20 445 initially untreated individuals, WCH (defined as high clinic BP but normal out-of-office BP, either by ambulatory of home measurements) was associated with an adjusted 38 and 20% increased risk of cardiovascular disease and total mortality compared with normotension. 3 Originally limited to untreated individuals, the definition has more recently been generalized to individuals treated with BP lowering drugs in whom only clinic BP fails to reach the therapeutic target (ie, white coat uncontrolled hypertension [WUCH]).
The association of WUCH with cardiovascular disease and mortality has been reported to be somewhat weaker than that of WCH.
Findings from a registry-based, multicenter, national cohort including 63 910 adults showed that WUCH, unlike WCH, exhibited a nonsignificant increase in full-adjusted risk of cardiovascular (HR 1.04, CI: 0.65-1.66, P = .86) and all-cause mortality (HR 1.06, CI: 0.82-1.37, P = .66). 4 The outcome discrepancy in WCH and WUCH is probably due to the fact that this latter group is more likely to have more frequent medical checks that, in turn, impact favorably on a variety of unhealthy conditions contributing to total cardiovascular risk and, last but not least, benefits from the protective effect of antihypertensive drugs.
Since WCH is quite frequently diagnosed in everyday clinical practice, this condition has important implications for public health. In a practical perspective, the large discrepancy between the two guidelines in detecting BP patterns at different cardiovascular risks (ie, WCH/WUCH versus sustained/uncontrolled hypertension) observed in our registry-based study urgently raises the problem of defining shared diagnostic criteria aimed at optimizing therapeutic strategies worldwide.
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